Adults 18–75 who’ve been diagnosed with hypothyroidism or Hashimoto’s and have been on a stable dose of levothyroxine (50 mcg or more) for at least 12 weeks may qualify.
Every participant receives the study medication — this Phase 3 trial has no placebo group.
Compensation up to $1,200 for participation, with no cost to join and no insurance required, at our Miami Lakes and Palm Springs locations.
Inquire today about our active clinical trials. Take a step toward creating a better future and advancing medical care solutions.
Not sure if you’re ready? One of our team members will guide you through the entire process to see if you’re a good fit.
Start by submitting the form below or calling 1-800-733-7962 today!